Retour sur lavenir.net
   KINEPOLIS GROUP 50.300 € (0,00 %)     UMICORE 18.110 € (-2,84 %)     AB INBEV 76.500 € (+1,19 %)     VASTNED 27.650 € (+1,10 %)     ONWARD MEDICAL 1.720 € (-2,82 %)     ARGENX SE 886.600 € (+1,28 %)     GIMV 50.500 € (-0,20 %)     ENERGYVISION 17.980 € (+1,12 %)     MELEXIS 57.650 € (+1,68 %)     SOLVAY 24.700 € (+1,15 %)     NYXOAH 0.790 € (-1,00 %)     BEKAERT 42.750 € (+3,51 %)     BPOST 0.863 € (-0,80 %)     AEDIFICA 65.900 € (+0,53 %)     WDP 19.760 € (+0,66 %)     TITAN S.A. 45.740 € (-1,25 %)     KBC 115.600 € (-4,34 %)     CMB.TECH 15.640 € (+0,77 %)     UCB 295.200 € (+1,34 %)     COLRUYT 37.080 € (+0,05 %)     EVS 17.720 € (-6,04 %)     RECTICEL 12.900 € (+1,57 %)     ASCENCIO 53.700 € (+0,19 %)     ELIA GROUP 135.100 € (+0,67 %)     AGEAS 79.250 € (+0,38 %)     SOFINA 269.800 € (-0,30 %)     LOTUS BAKERIES 14 200.000 € (+0,42 %)     SYENSQO 79.500 € (-0,62 %)     SIPEF 108.400 € (-0,73 %)     CIE BOIS SAUVAGE 287.000 € (-0,35 %)     OXURION 0.001 € (0,00 %)     CELYAD ONCOLOGY 0.170 € (-5,03 %)     DEME GROUP 168.600 € (+0,84 %)     KBC ANCORA 95.500 € (-1,95 %)     TINC 10.580 € (-0,19 %)     FAGRON 24.200 € (-0,62 %)     JENSEN-GROUP 76.000 € (-0,26 %)     MONTEA 70.700 € (+1,29 %)     SHURGARD 25.900 € (-0,96 %)     SOLVAC 86.000 € (-1,15 %)     ACKERMANS V.HAAREN 279.000 € (+1,09 %)     TUBIZE-FIN 242.000 € (+0,75 %)     BREDERODE 100.200 € (-0,60 %)     CARE PROPERTY INV. 12.800 € (-0,31 %)     AGFA-GEVAERT 0.361 € (+1,55 %)     BARCO 6.265 € (+0,08 %)     PROXIMUS 6.450 € (+1,65 %)     XIOR 25.650 € (+0,20 %)     RETAIL ESTATES 63.500 € (-0,94 %)     OPTION 4.500 € (-3,85 %)     HOME INVEST BE. 18.040 € (+0,78 %)     ECONOCOM GROUP 1.490 € (-2,61 %)     BIOTALYS 1.904 € (-3,74 %)     HYLORIS 3.980 € (-5,24 %)     D'IETEREN GROUP 176.000 € (0,00 %)     AZELIS GROUP 12.000 € (+2,30 %)     VGP 65.600 € (+1,39 %)     EKOPAK 2.900 € (+3,57 %)     NEXTENSA 45.815 € (-0,73 %)     WERELDHAVE BELGIUM 52.000 € (0,00 %)  
   LVMH 404.700 € (+0,40 %)     TOTALENERGIES 80.630 € (+1,59 %)     HEIJMANS KON 87.150 € (-1,13 %)     VALEO 11.255 € (-2,34 %)     COMPAGNIE ODET 1 020.000 € (+2,00 %)     SCHNEIDER ELECTRIC 244.800 € (+0,95 %)     SHELL PLC 44.120 € (+0,78 %)     COVIVIO HOTELS 19.850 € (-2,22 %)     ADYEN 868.000 € (-0,75 %)     ASM INTERNATIONAL 724.200 € (-0,47 %)     ABEO 6.700 € (+3,72 %)     SAFRAN 312.300 € (-0,06 %)     ASML HOLDING 1 376.800 € (-1,92 %)     THALES 227.400 € (-1,30 %)     BE SEMICONDUCTOR 158.050 € (-1,06 %)     HERMES INTL 1 352.500 € (-0,07 %)     AIRBUS 208.250 € (-1,16 %)     OCI 4.090 € (0,00 %)     KENDRION 17.940 € (0,00 %)     ING GROEP N.V. 30.010 € (-0,50 %)     ENGIE 25.140 € (+1,53 %)     EURONEXT 166.200 € (-0,72 %)     AHOLD DEL 35.300 € (+0,23 %)     SANOFI 87.980 € (+1,58 %)     ABIVAX 82.500 € (-0,96 %)     EUROPLASMA 0.000 € (0,00 %)     ADP 116.800 € (-0,17 %)     UNILEVER 59.180 € (+0,94 %)     CREDIT AGRICOLE 15.830 € (-0,25 %)     HAFFNER ENERGY 0.568 € (-1,22 %)     VEOLIA ENVIRON. 34.660 € (+1,05 %)     UNIBAIL-RODAMCO-WE 93.140 € (-0,26 %)     OSE IMMUNO 1.702 € (-1,96 %)     GENOWAY 2.030 € (+6,28 %)     ARCADIS 47.460 € (+0,38 %)     GTT 186.800 € (-0,11 %)     STMICROELECTRONICS 42.340 € (+0,39 %)     SPINEGUARD 0.090 € (+1,35 %)     BRUNEL INTERNAT 7.000 € (+2,04 %)     MEDINCELL 29.080 € (-2,48 %)     LAURENT-PERRIER 79.400 € (-1,49 %)     CSG 10.016 € (-4,97 %)     SMCP 4.112 € (-1,15 %)     OMER-DECUGIS & CIE 7.000 € (+0,86 %)     S.E.B. 57.150 € (-0,70 %)     BIOPHYTIS 0.039 € (-4,38 %)     PHILIPS KON 27.260 € (+0,48 %)     EXOR NV 73.400 € (-1,41 %)     SOLUTIONS 30 SE 0.550 € (+3,19 %)     EIFFAGE 109.350 € (+0,60 %)     SWORD GROUP 34.900 € (+3,10 %)     ORANGE 15.485 € (+0,42 %)     COHERIS 7.020 € (0,00 %)     CTP 12.860 € (-0,46 %)     AIR LIQUIDE 192.840 € (+0,35 %)     MR BRICOLAGE 2.750 € (-1,08 %)     UV GERMI 2.350 € (+1,29 %)     SIGNIFY NV 15.670 € (-1,20 %)     INTERPARFUMS 36.380 € (-0,27 %)     MEDIAN TECH BSA 3.280 € (+9,33 %)  
BELGRANO
BGO - - Euronext Paris
7,600 €  17:35
+0,26 %
12/11/2026 23:12

Belgrano continues the implementation of its public share buyback offer (OPRA)

PRESS RELEASE
Paris, November 12, 2026

Belgrano continues the implementation of its public share buyback offer
(OPRA)

An operation approved by the Extraordinary General Meeting of Shareholders

In accordance with recent communications, the preparation of the OPRA project continues its deployment according to the planned schedule, with a targeted completion in the first quarter of 2027. The Extraordinary General Meeting of Shareholders, held on October 20, 2026, approved by a very large majority the reduction in the Company's share capital, which will be implemented following the completion of the OPRA.

As a reminder, the OPRA involves a maximum overall amount of 36,249,990 euros, corresponding to the buyback of a maximum of 2,589,285 shares of the Company, representing approximately 10.38% of its share capital and 9.90% of the Company's voting rights, at a maximum unit price of 14 euros per share. This price remains subject to the conclusions of the ongoing voluntary independent appraisal.

The shares thus bought back will subsequently be cancelled as part of the capital reduction.

Approval obtained from the Group's banking and financial partners

The various approvals from the Group's banking and financial partners necessary for the completion of the OPRA have been obtained.

As a reminder, the Company’s Board of Directors voluntarily decided to commission an independent appraisal. Consequently, the completion of the OPRA is no longer subject to any conditions precedent other than the issuance of the independent expert's report on the fairness of the price offered as part of the OPRA and the issuance of a clearance decision by the French financial market authority (Autorité des marchés financiers – AMF) on the OPRA.

Continuation of the work of the ad hoc Committee and the independent expert

As announced last September, and in accordance with the provisions of Article 261-3 of the General Regulation of the AMF, the Company's Board of Directors, acting on the recommendation of the ad hoc committee—composed of three directors, including two independent directors, as defined by the Middlenext Code, Mr. Augustin de Romanet, independent director, Ms. Alexandra Rocca, independent director, and Colombus Holding SAS, non-independent director, represented by Mr. Emmanuel Coquoin—voluntarily appointed, in accordance with Article 261-1, III of the AMF General Regulation, the firm Kling Expertise & Evaluation, represented by Mr. Didier Kling and Mr. Teddy Guérineau, as independent expert.

The independent expert's mission is to prepare a report on the financial terms of the OPRA, the conclusion of which is presented in the form of a fairness opinion, in accordance with the provisions of the AMF General Regulation and AMF Recommendation DOC-2006-15.

The independent expert is currently continuing its analysis and valuation work, under the supervision of the ad hoc committee with which several meetings have been held.

Group Financial Communication // +33 1 47 04 13 40 // comfin@belgranogroup.com
www.belgranogroup.com

PRESS RELEASE
Paris, November 12, 2026

Shareholders wishing to submit comments or questions regarding the financial terms of the transaction may contact the independent expert at the following contact details:

Cabinet Kling Expertise & Evaluation
To the attention of Mr. Didier Kling and Mr. Teddy Guérineau
11, rue Chateaubriand 75008 Paris
Email: didier.kling@kling-associes.fr and teddy.guerineau@kling-associes.fr

Next steps and implementation schedule for the OPRA

The independent expert's report and the Board of Directors' reasoned opinion will be made public as part of the draft information document (note d'information) relating to the OPRA to be prepared by the Company, which will be filed with the AMF in the coming weeks. The filing of the draft information document will be announced by the Company in a separate press release.

The completion of the OPRA will remain subject to the AMF's review of the draft offer and its clearance decision. The AMF's clearance decision will determine the opening date and the settlement-delivery date of the offer.

Following the AMF's clearance decision, the information document approved by the AMF will be made available to the public and will be the subject of a Company press release specifying, in particular, the terms and schedule of the offer.

The actual completion of the transaction, including the settlement and delivery of the shares tendered to the offer, is expected during the first quarter of 2027.

ABOUT BELGRANO

Belgrano, operating under the signature Architect of Rarity, is a hybrid company that acts both as an operator and developer of businesses positioned in new high-luxury goods and services categories, and as an investor committed to the active management of a portfolio of rare, prestigious assets with strong historical roots. Backed by the long-term commitment of the Fribourg Family Group, its controlling shareholder, the Group implements a value creation strategy based on holding, developing, and enhancing its unique portfolio of differentiating assets. As of June 30, 2026, Belgrano’s net asset value stands at €556 million.

The share is listed on Euronext Paris and is eligible for the PEA-PME equity savings plan.
ISIN Code: FR0000130692, Bloomberg Ticker: CRI:FP, Reuters Ticker: CRIP.PA

Group Financial Communication // +33 1 47 04 13 40 // comfin@belgranogroup.com
www.belgranogroup.com

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière